Loading clinical trials...

Anticoagulation for Aortic Bioprosthesis (ANTIPRO) | Clinical Trials | Clareo Health

COMPLETEDPhase 4NCT03807921

Anticoagulation for Aortic Bioprosthesis (ANTIPRO)

This study evaluates the clinical and hemodynamic outcome in patients after aortic valve replacement. Half of the patients will receive warfarin + aspirin and the other half will receive only aspirin....

Lead sponsor: Instituto Nacional de Cirugia Cardiaca, Uruguay•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITING

Prospective Long-Term Outcomes of a Standardized Ross Procedure

NCT06352671 · Aortic Valve Disease

RECRUITINGPhase 2/3

Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study

NCT07001800 · Moderate Aortic Valve Stenosis

RECRUITING

REdo Transcatheter Aortic VALVE Implantation for the Management of Transcatheter Aortic Valve Failure

NCT06557798 · Aortic Valve Stenosis

RECRUITING

Real World Data Collection on the INSPIRIS RESILIA Aortic Valve

NCT07120048 · Aortic Valve Disease

RECRUITINGNA

Post-Dilatation Effect on TAVI Prostheses Expansion

NCT07477002 · Aortic Valve Stenosis

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 8, 2022Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE4

Enrollment140

Start dateJan 2019

Last updatedMar 8, 2022

Condition

Aortic Valve Stenosis Aortic Valve Disease Aortic Valve Insufficiency Aortic Valve Regurgitation

Locations shown

Centro Cardiovascular Universitario

Montevideo

Instituto Nacional de Cirugia Cardiaca

Montevideo

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 8, 2022Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Anticoagulation for Aortic Bioprosthesis (ANTIPRO)

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Sponsors

Related studies

Prospective Long-Term Outcomes of a Standardized Ross Procedure

Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study

REdo Transcatheter Aortic VALVE Implantation for the Management of Transcatheter Aortic Valve Failure

Real World Data Collection on the INSPIRIS RESILIA Aortic Valve

Post-Dilatation Effect on TAVI Prostheses Expansion

Trial snapshot

Condition

Locations shown

For caregivers